Stay updated on Dupilumab for Chronic Hands Eczema - Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Chronic Hands Eczema - Clinical Trial page.

Latest updates to the Dupilumab for Chronic Hands Eczema - Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error for the study record, replacing the previous content with an access-denied message and standard site chrome; the study details are no longer visible in this view.SummaryDifference18%

- Check10 days agoChange DetectedThe page now shows Revision: v3.7.0 to reflect the latest document version, and the older Revision: v3.6.6 label has been removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision has moved from v3.6.5 to v3.6.6, indicating a newer build of the page. This typically reflects minor fixes or improvements rather than changes to the displayed study information.SummaryDifference0.1%

- Check31 days agoChange DetectedAn NIH grant/contract entry for 2018 was added to the study's funding/identifiers section, indicating U.S. NIH support for this trial.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows a new revision label, v3.6.5, replacing the previous v3.6.4. This indicates an updated build or metadata for the study details page without altering the displayed content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a small maintenance update. It does not reflect changes to the study details or results, only the page's versioning.SummaryDifference0.1%

Stay in the know with updates to Dupilumab for Chronic Hands Eczema - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Chronic Hands Eczema - Clinical Trial page.